Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis

Recent trials have shown a promising anti-tumor activity for advanced cancer patients treated with PD-1/PD-L1 inhibitors; however, little is known on the use of PD-1/PD-L1 inhibitors in adults over 75 years of age. Here, we performed a study-level meta-analysis to compare the efficacy of anti-PD-1/P...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Run-Cong, Chen, Guo-Ming, Wang, Yun, Zhou, Jie, Duan, Jin-Ling, Zhou, Zhi-Wei, Yuan, Shu-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018595/
https://www.ncbi.nlm.nih.gov/pubmed/33816215
http://dx.doi.org/10.3389/fonc.2021.538174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018595/
https://www.ncbi.nlm.nih.gov/pubmed/33816215
http://dx.doi.org/10.3389/fonc.2021.538174

Ejemplares similares